Status:
COMPLETED
The Effect of Platelet Rich Plasma on Partial Thickness Rotator Cuff Tears: A Randomized Controlled Trial
Lead Sponsor:
University of Calgary
Conditions:
Rotator Cuff Injuries
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Randomized controlled trial examining platelet rich plasma versus corticosteroid injection in partial thickness rotator cuff tears or tendinopathy.
Detailed Description
We performed a randomized controlled trial on patients with imaging-shown rotator cuff tendinopathy or partial thickness tearing. Patients were randomized to receive either platelet rich plasma or cor...
Eligibility Criteria
Inclusion
- \>18 years
- MRI or US evidence of supraspinatus tendinopathy or partial thickness tearing
- symptomatic for minimum of 3 months
- patient has exhausted a course of adequate conservative treatment (including but not limited to home/out patient physical therapy, oral analgesics, and/or shoulder injections)
Exclusion
- prior surgical intervention on affected shoulder
- full thickness rotator cuff tear
- concomitant ipsilateral shoulder pathology (i.e. osteoarthritis, inflammatory arthritis)
- confounding cervical neck pain or radiculopathy
- more than 3 previous CS injections
- a CS injection within 6 months of study intervention
- elite level athlete
- worker's compensation case
- litigation or secondary gain issues
- unwilling or unable to provide informed consent or complete study outcomes
Key Trial Info
Start Date :
March 13 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 6 2019
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04743986
Start Date
March 13 2015
End Date
June 6 2019
Last Update
February 8 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.